Review
Cellular responses to cisplatin. The roles of DNA-binding proteins and DNA repair
Affiliations
- PMID: 8288625
Item in Clipboard
Review
Cellular responses to cisplatin. The roles of DNA-binding proteins and DNA repair
J Biol Chem.
.
Free article
Abstract
The anticancer drug cisplatin provokes a complex response in the cell. A lethal dose of the drug kills cells primarily by forming DNA adducts, causing G2 arrest in the cell cycle, and then triggering apoptosis. A sublethal dose induces drug resistance by several mechanisms, including changes in drug uptake and efflux, glutathione and metallothionein levels, and DNA repair. Cisplatin-DNA adducts bind several cellular proteins, including some that enhance survival of the cell by mediating DNA repair and others that hasten its death by conferring sensitivity to the drug.
Similar articles
-
Molecular basis of cis-diamminedichloroplatinum(II) resistance: a review.J Formos Med Assoc. 1996 Dec;95(12):893-900. J Formos Med Assoc. 1996. PMID: 9000804 Review.
-
The mismatch-repair protein hMSH2 binds selectively to DNA adducts of the anticancer drug cisplatin.Chem Biol. 1996 Jul;3(7):579-89. doi: 10.1016/s1074-5521(96)90149-0. Chem Biol. 1996. PMID: 8807890
-
The role of hMLH1, hMSH3, and hMSH6 defects in cisplatin and oxaliplatin resistance: correlation with replicative bypass of platinum-DNA adducts.Cancer Res. 1998 Aug 15;58(16):3579-85. Cancer Res. 1998. PMID: 9721864
-
Mechanisms of resistance to cisplatin.Mutat Res. 2001 Jul 1;478(1-2):23-43. doi: 10.1016/s0027-5107(01)00141-5. Mutat Res. 2001. PMID: 11406167 Review.
-
Development of resistance to a trinuclear platinum complex in ovarian carcinoma cells.Int J Cancer. 2003 Jul 10;105(5):617-24. doi: 10.1002/ijc.11140. Int J Cancer. 2003. PMID: 12740909
Cited by
-
Fasnall, a Selective FASN Inhibitor, Shows Potent Anti-tumor Activity in the MMTV-Neu Model of HER2(+) Breast Cancer.Cell Chem Biol. 2016 Jun 23;23(6):678-88. doi: 10.1016/j.chembiol.2016.04.011. Epub 2016 Jun 2. Cell Chem Biol. 2016. PMID: 27265747 Free PMC article.
-
A novel charged trinuclear platinum complex effective against cisplatin-resistant tumours: hypersensitivity of p53-mutant human tumour xenografts.Br J Cancer. 1999 Aug;80(12):1912-9. doi: 10.1038/sj.bjc.6690620. Br J Cancer. 1999. PMID: 10471039 Free PMC article.
-
Novel combination treatment for colorectal cancer using Nek2 siRNA and cisplatin.Cancer Sci. 2010 May;101(5):1163-9. doi: 10.1111/j.1349-7006.2010.01504.x. Epub 2010 Jan 20. Cancer Sci. 2010. PMID: 20345485 Free PMC article.
-
Inhibition of cell growth, induction of apoptosis and mechanism of action of the novel platinum compound cis-diaminechloro-[2-(diethylamino) ethyl 4-amino-benzoate, N(4)]-chloride platinum (II) monohydrochloride monohydrate.Invest New Drugs. 2004 Jan;22(1):3-16. doi: 10.1023/b:drug.0000006170.38419.c9. Invest New Drugs. 2004. PMID: 14707490
-
Apoptosis-related mRNA expression profiles of ovarian cancer cell lines following cisplatin treatment.J Gynecol Oncol. 2010 Dec 30;21(4):255-61. doi: 10.3802/jgo.2010.21.4.255. Epub 2010 Dec 31. J Gynecol Oncol. 2010. PMID: 21278888 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
